Logo image of TESB.BR

TESSENDERLO GROUP (TESB.BR) Stock Fundamental Analysis

EBR:TESB - Euronext Brussels - BE0003555639 - Common Stock - Currency: EUR

26.95  +0.15 (+0.56%)

Fundamental Rating

5

Taking everything into account, TESB scores 5 out of 10 in our fundamental rating. TESB was compared to 66 industry peers in the Chemicals industry. Both the profitability and the financial health of TESB get a neutral evaluation. Nothing too spectacular is happening here. TESB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

TESB had positive earnings in the past year.
TESB had a positive operating cash flow in the past year.
In the past 5 years TESB has always been profitable.
In the past 5 years TESB always reported a positive cash flow from operatings.
TESB.BR Yearly Net Income VS EBIT VS OCF VS FCFTESB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

TESB's Return On Assets of 1.46% is in line compared to the rest of the industry. TESB outperforms 54.55% of its industry peers.
With a Return On Equity value of 2.26%, TESB perfoms like the industry average, outperforming 51.52% of the companies in the same industry.
TESB has a Return On Invested Capital of 2.05%. This is comparable to the rest of the industry: TESB outperforms 45.45% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for TESB is in line with the industry average of 6.51%.
The last Return On Invested Capital (2.05%) for TESB is well below the 3 year average (6.25%), which needs to be investigated, but indicates that TESB had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.46%
ROE 2.26%
ROIC 2.05%
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
TESB.BR Yearly ROA, ROE, ROICTESB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 1.62%, TESB is in line with its industry, outperforming 51.52% of the companies in the same industry.
TESB's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 2.41%, TESB perfoms like the industry average, outperforming 42.42% of the companies in the same industry.
TESB's Operating Margin has declined in the last couple of years.
The Gross Margin of TESB (19.38%) is worse than 72.73% of its industry peers.
TESB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.41%
PM (TTM) 1.62%
GM 19.38%
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
TESB.BR Yearly Profit, Operating, Gross MarginsTESB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TESB is destroying value.
The number of shares outstanding for TESB has been reduced compared to 1 year ago.
Compared to 5 years ago, TESB has more shares outstanding
The debt/assets ratio for TESB is higher compared to a year ago.
TESB.BR Yearly Shares OutstandingTESB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
TESB.BR Yearly Total Debt VS Total AssetsTESB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.08 indicates that TESB is not a great score, but indicates only limited risk for bankruptcy at the moment.
TESB has a Altman-Z score of 2.08. This is comparable to the rest of the industry: TESB outperforms 46.97% of its industry peers.
The Debt to FCF ratio of TESB is 1.69, which is an excellent value as it means it would take TESB, only 1.69 years of fcf income to pay off all of its debts.
TESB has a Debt to FCF ratio of 1.69. This is amongst the best in the industry. TESB outperforms 93.94% of its industry peers.
TESB has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
TESB's Debt to Equity ratio of 0.07 is amongst the best of the industry. TESB outperforms 89.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.69
Altman-Z 2.08
ROIC/WACC0.29
WACC7.12%
TESB.BR Yearly LT Debt VS Equity VS FCFTESB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 2.11 indicates that TESB has no problem at all paying its short term obligations.
The Current ratio of TESB (2.11) is better than 66.67% of its industry peers.
A Quick Ratio of 1.18 indicates that TESB should not have too much problems paying its short term obligations.
TESB has a Quick ratio of 1.18. This is comparable to the rest of the industry: TESB outperforms 56.06% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 1.18
TESB.BR Yearly Current Assets VS Current LiabilitesTESB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

TESB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -60.46%.
The earnings per share for TESB have been decreasing by -20.75% on average. This is quite bad
TESB shows a decrease in Revenue. In the last year, the revenue decreased by -9.58%.
The Revenue has been growing by 8.72% on average over the past years. This is quite good.
EPS 1Y (TTM)-60.46%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-162.24%
Revenue 1Y (TTM)-9.58%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%-3.32%

3.2 Future

TESB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.03% yearly.
Based on estimates for the next years, TESB will show a small growth in Revenue. The Revenue will grow by 2.57% on average per year.
EPS Next Y39.56%
EPS Next 2Y33.42%
EPS Next 3Y11.03%
EPS Next 5YN/A
Revenue Next Year4.65%
Revenue Next 2Y4.39%
Revenue Next 3Y2.57%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TESB.BR Yearly Revenue VS EstimatesTESB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
TESB.BR Yearly EPS VS EstimatesTESB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 39.63, which means the current valuation is very expensive for TESB.
Based on the Price/Earnings ratio, TESB is valued a bit more expensive than the industry average as 60.61% of the companies are valued more cheaply.
When comparing the Price/Earnings ratio of TESB to the average of the S&P500 Index (26.25), we can say TESB is valued expensively.
With a Price/Forward Earnings ratio of 16.83, TESB is valued correctly.
TESB's Price/Forward Earnings ratio is in line with the industry average.
TESB's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.15.
Industry RankSector Rank
PE 39.63
Fwd PE 16.83
TESB.BR Price Earnings VS Forward Price EarningsTESB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

TESB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. TESB is cheaper than 84.85% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, TESB is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.62
EV/EBITDA 5.62
TESB.BR Per share dataTESB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

TESB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1
PEG (5Y)N/A
EPS Next 2Y33.42%
EPS Next 3Y11.03%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.97%, TESB has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.12, TESB has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, TESB has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.97%

5.2 History

The dividend of TESB is nicely growing with an annual growth rate of 6.16%!
Dividend Growth(5Y)6.16%
Div Incr Years0
Div Non Decr Years1
TESB.BR Yearly Dividends per shareTESB.BR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

126.17% of the earnings are spent on dividend by TESB. This is not a sustainable payout ratio.
TESB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP126.17%
EPS Next 2Y33.42%
EPS Next 3Y11.03%
TESB.BR Yearly Income VS Free CF VS DividendTESB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
TESB.BR Dividend Payout.TESB.BR Dividend Payout, showing the Payout Ratio.TESB.BR Dividend Payout.PayoutRetained Earnings

TESSENDERLO GROUP

EBR:TESB (5/30/2025, 7:00:00 PM)

26.95

+0.15 (+0.56%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-26 2025-03-26/amc
Earnings (Next)08-21 2025-08-21
Inst Owners4.44%
Inst Owner ChangeN/A
Ins Owners47.46%
Ins Owner ChangeN/A
Market Cap1.62B
Analysts78
Price Target27.54 (2.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.97%
Yearly Dividend0.88
Dividend Growth(5Y)6.16%
DP126.17%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)4.9%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.81%
Revenue NY rev (3m)-2.81%
Valuation
Industry RankSector Rank
PE 39.63
Fwd PE 16.83
P/S 0.61
P/FCF 10.62
P/OCF 4.87
P/B 0.86
P/tB 1.03
EV/EBITDA 5.62
EPS(TTM)0.68
EY2.52%
EPS(NY)1.6
Fwd EY5.94%
FCF(TTM)2.54
FCFY9.41%
OCF(TTM)5.54
OCFY20.55%
SpS44.01
BVpS31.52
TBVpS26.21
PEG (NY)1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.46%
ROE 2.26%
ROCE 2.73%
ROIC 2.05%
ROICexc 2.3%
ROICexgc 2.71%
OM 2.41%
PM (TTM) 1.62%
GM 19.38%
FCFM 5.76%
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
ROICexc(3y)6.83%
ROICexc(5y)8.71%
ROICexgc(3y)7.61%
ROICexgc(5y)9.79%
ROCE(3y)8.33%
ROCE(5y)10.06%
ROICexcg growth 3Y-43.17%
ROICexcg growth 5Y-19.86%
ROICexc growth 3Y-44.09%
ROICexc growth 5Y-20.16%
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
F-Score6
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.69
Debt/EBITDA 0.49
Cap/Depr 85.39%
Cap/Sales 6.82%
Interest Coverage 7.01
Cash Conversion 121.03%
Profit Quality 356.54%
Current Ratio 2.11
Quick Ratio 1.18
Altman-Z 2.08
F-Score6
WACC7.12%
ROIC/WACC0.29
Cap/Depr(3y)86.45%
Cap/Depr(5y)81.94%
Cap/Sales(3y)5.77%
Cap/Sales(5y)5.54%
Profit Quality(3y)143.93%
Profit Quality(5y)139.31%
High Growth Momentum
Growth
EPS 1Y (TTM)-60.46%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-162.24%
EPS Next Y39.56%
EPS Next 2Y33.42%
EPS Next 3Y11.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.58%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%-3.32%
Revenue Next Year4.65%
Revenue Next 2Y4.39%
Revenue Next 3Y2.57%
Revenue Next 5YN/A
EBIT growth 1Y-46.88%
EBIT growth 3Y-34.22%
EBIT growth 5Y-13.98%
EBIT Next Year266.59%
EBIT Next 3Y56.25%
EBIT Next 5YN/A
FCF growth 1Y274.94%
FCF growth 3Y0.11%
FCF growth 5Y5.75%
OCF growth 1Y52.01%
OCF growth 3Y10.33%
OCF growth 5Y8.69%